PulseAugur
LIVE 08:22:05
ENTITY Rilafuvirt-alpha injection

Rilafuvirt-alpha injection

PulseAugur coverage of Rilafuvirt-alpha injection — every cluster mentioning Rilafuvirt-alpha injection across labs, papers, and developer communities, ranked by signal.

Total · 30d
1
1 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
SENTIMENT · 30D

1 day(s) with sentiment data

RECENT · PAGE 1/1 · 1 TOTAL
  1. RESEARCH · CL_29806 ·

    Hengrui Medicine subsidiaries get drug trial approvals; Xiangcai merger review resumes

    Hengrui Medicine announced that its subsidiaries have received approval from China's National Medical Products Administration for clinical trials of three drugs. These include SHR-3821 for advanced solid tumors, Adebeli…